A recent study published in Social Science & Medicine highlights the ongoing racial and ethnic disparities in colorectal cancer (CRC) mortality in the United States. Despite advancements in CRC care, Black and American Indian/Alaska Native (AI/AN) patients continue to face the highest risks of death from this disease. The research, led by Qi and colleagues, utilized data from the Surveillance, Epidemiology, and End Results registry, analyzing trends from 1992 to 2021.
The study found that while the overall 5-year cumulative incidence of CRC and all-cause mortality among Black patients has declined, these patients still consistently face higher mortality rates compared to other racial groups. AI/AN patients also experience significant disparities, with persistent gaps in mortality rates despite some improvements in care.
Factors contributing to these disparities include stage at diagnosis, initial treatment, and socioeconomic status. However, the study also points to unmeasured factors such as structural racism, which play a crucial role in these inequities. The researchers emphasize the urgent need for targeted interventions to address these disparities and improve outcomes for minority communities.
The findings underscore the importance of equitable access to cancer screening and treatment. Addressing low cancer screening utilization and socioeconomic disparities is crucial for reducing racial and ethnic inequities in CRC outcomes. The study calls for new interventions to eliminate health disparities and ensure better health for all patients, regardless of their racial or ethnic background.
See: “Racial Disparities Exist in Colorectal Cancer Deaths” (May 8, 2025)
